Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 80/100

Failure Rate

50.0%

4 terminated/withdrawn out of 8 trials

Success Rate

42.9%

-43.6% vs industry average

Late-Stage Pipeline

13%

1 trials in Phase 3/4

Results Transparency

100%

3 of 3 completed trials have results

Key Signals

3 with results

Enrollment Performance

Analytics

N/A
4(50.0%)
Phase 2
2(25.0%)
Phase 1
1(12.5%)
Phase 3
1(12.5%)
8Total
N/A(4)
Phase 2(2)
Phase 1(1)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials
NCT01541098Phase 2Withdrawn

A Clinical Study of Lyophilized Plasma in Patients on Warfarin

Role: lead

NCT01547078Phase 2Withdrawn

Clinical Study of Lyophilized Plasma in Patients With Liver Disease

Role: lead

NCT01035944Not ApplicableTerminated

Chitosan Dressings to Facilitate Safe Effective Debridement of Chronic Wounds & Minimize Wound Bacterial Re-colonization

Role: lead

NCT00707486Phase 3Completed

A Randomized, Self Controlled Clinical Study of Hemostatic Efficacy of the HemCon Dental Dressing

Role: lead

NCT00863356Not ApplicableCompleted

Trial of a Novel Chitosan Hemostatic Sealant in the Management of Complicated Epistaxis

Role: lead

NCT00707564Not ApplicableWithdrawn

Study of Hemostatic Efficacy of the HemCon Dental Dressing in a Population Treated With Anticoagulant Medications

Role: lead

NCT00968487Phase 1Completed

The Safety of Autologous Lyophilized Plasma Versus Fresh Frozen Plasma in Healthy Volunteers

Role: lead

NCT01373801Not ApplicableUnknown

Hemcon© Bandage for Postpartum Bleeding Due to the Multiple Vaginal Lacerations

Role: collaborator

All 8 trials loaded